| AKI | Acute Kidney Injury |
| APACHE II | Acute Physiology and Chronic Health Evaluation II |
| ARC | Augmented Renal Clearance |
| AUC | Area Under the Concentration–Time Curve |
| CI | Confidence Interval |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| eGFR | Estimated Glomerular Filtration Rate |
| HAP | Hospital-Acquired Pneumonia |
| ICU | Intensive Care Unit |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| MIC | Minimum Inhibitory Concentration |
| MRSA | Methicillin-Resistant Staphylococcus aureus |
| OR | Odds Ratio |
| PK/PD | Pharmacokinetic/Pharmacodynamic |
| SAPS | Simplified Acute Physiology Score |
| sCAP | severe Community-Acquired Pneumonia |
| SD | Standard Deviation |
| SOFA | Sequential Organ Failure Assessment |
| TDM | Therapeutic Drug Monitoring |
| TIR | Time in Therapeutic Range |
| VAP | Ventilator-Associated Pneumonia |
| VRE | Vancomycin-Resistant Enterococcus |
| VTC | Vancomycin Trough Concentration |